FCRN-BINDING ABOLISHED ANTI-IGF-1R ANTIBODIES AND THEIR USE IN THE TREATMENT OF VASCULAR EYE DISEASES

The invention provides anti-IGF-lR antibodies with abolished FcRn-binding and methods of using the same for the treatment of vascular eye diseases.

Saved in:
Bibliographic Details
Main Authors MATTHIAS RUETH, JOERG THOMAS REGULA, WOLFGANG SCHAEFER, TILMAN SCHLOTHAUER, GUIDO HARTMANN
Format Patent
LanguageEnglish
Published 14.01.2021
Subjects
CHEMISTRY
METALLURGY
ORGANIC CHEMISTRY
PEPTIDES
Online AccessGet full text

Cover

More Information
Summary:The invention provides anti-IGF-lR antibodies with abolished FcRn-binding and methods of using the same for the treatment of vascular eye diseases.
Bibliography:Application Number: MY2015PI703843